Connect with us


Lok Sabha Speaker Om Birla Lauds Country’s Scientists For Developing COVID-19 Vaccine

In India, the government has given emergency use authorisation to two COVID-19 vaccines – Oxford-AstraZeneca’s Covishield and Bharat Biotech’s Covaxin

Lok Sabha Speaker Om Birla Lauds Country's Scientists For Developing COVID-19 Vaccine
  • Our scientists made high-quality vaccines in a short span of time: Mr Birla
  • Rs 35,000 crore has been provided for COVID-19 vaccines in the Budget 2021
  • India’s vaccination drive began on January 16; over 50 lakh vaccinated

New Delhi: Lok Sabha Speaker Om Birla on Friday (February 5) praised India’s scientists for developing COVID-19 vaccines in a short span of time and said they had earned laurels for the country. “I would like to thank our scientists on behalf of the House. They made high-quality vaccines in a short span of time and earned praise for the country in the world. I hope that they will continue making their contributions with the same spirit in the service of the country,” Mr Birla said.

Also Read: Second COVID-19 Vaccine Shot To Be Administered To Healthcare Workers From February 13: Dr VK Paul

He made the remarks in Lok Sabha after Union Health Minister Harsh Vardhan replied to queries regarding COVID-19 vaccination during question hour. The minister said the third phase of COVID-19 vaccination, in which people above 50 years of age will be vaccinated, is expected to start next month. Harsh Vardhan said Rs 35,000 crore has been provided for COVID-19 vaccines in the Union Budget 2021-22 and Finance Minister has assured that allocation can increase if required. The Health Minister also said that India has received requests for supply of COVID-19 vaccines from 22 countries so far and these have already been supplied to 15 countries.

We have received requests for vaccine supply from 22 nations so far. Out of these, supply has already been made to 15 nations as grant assistance as well as contract doses. As of February 2, a total of 56 lakh doses has been given as grant assistance and 105 lakh as contracts doses, the minister said.

The government has given emergency use authorisation to two vaccines– Covishield and Covaxin. The minister said that work was also being done on seven other vaccines in the country of which three are in phase three trials.

Also Read: COVID-19 Vaccine: WHO Expert Answers Frequently Asked Questions

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)

NDTV – Dettol Banega Swasth India campaign is an extension of the five-year-old Banega Swachh India initiative helmed by Campaign Ambassador Amitabh Bachchan. It aims to spread awareness about critical health issues facing the country. In wake of the current COVID-19 pandemic, the need for WASH (Water, Sanitation and Hygiene) is reaffirmed as handwashing is one of the ways to prevent Coronavirus infection and other diseases. The campaign highlights the importance of nutrition and healthcare for women and children to prevent maternal and child mortality, fight malnutrition, stunting, wasting, anaemia and disease prevention through vaccines. Importance of programmes like Public Distribution System (PDS), Mid-day Meal Scheme, POSHAN Abhiyan and the role of Aganwadis and ASHA workers are also covered. Only a Swachh or clean India where toilets are used and open defecation free (ODF) status achieved as part of the Swachh Bharat Abhiyan launched by Prime Minister Narendra Modi in 2014, can eradicate diseases like diahorrea and become a Swasth or healthy India. The campaign will continue to cover issues like air pollution, waste management, plastic ban, manual scavenging and sanitation workers and menstrual hygiene.

Highlights: Banega Swasth India Season 9 Finale

Folk Music For A Swasth India

Folk Music

Reckitt’s Commitment To A Better Future

India’s Unsung Heroes

Women’s Health

हिंदी में पढ़ें